News
In separate filings, Chief Legal Officer Soleil Boughton sold 2,572 shares at a price of $51.64 apiece for $132,818, while ...
This article covers key health news including Primary Health Properties securing a takeover bid for Assura, Novo Nordisk's ...
The Nasdaq and S&P 500 nabbed fresh record closes, while the Dow added more than 480 points as interest rate hopes soared ...
StockStory.org on MSN7h
Why Hims & Hers Health (HIMS) Shares Are Trading Lower Today
What Happened? Shares of telehealth company Hims & Hers Health (NYSE:HIMS) fell 3.6% in the afternoon session after the ...
Shares of Hims & Hers Health Inc. have roughly doubled over the past year, and Chief Executive Andrew Dudum cashed in on the ...
HIMS leverages its consumer-first telehealth model, AI-driven personalization and global expansion plans to outpace industry growth.
Hims & Hers Health ( NYSE: HIMS) shares traded lower for the second straight session on Tuesday after the telehealth firm’s ...
What Happened: According to a Form 4 filing with the U.S. Securities and Exchange Commission on Monday, Dudum sold 660,000 shares of Hims & Hers Health. The total transaction value is $33,384,120. The ...
12h
Investor's Business Daily on MSNStocks With Rising Relative Strength: Natera
The Relative Strength (RS) Rating for Natera NTRA jumped into a new percentile Tuesday, as it got a lift from 63 to 71.
Current health news covers Novo Nordisk's ongoing lawsuits over Wegovy copies, influencer Michelle Miller's push for GMOs, IO Biotech's narrowly missed cancer vaccine goal, and China's ban on Spanish ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results